Sedana Medical AB (SE:SEDANA)
:SEDANA
Want to see SE:SEDANA full AI Analyst Report?
SEDANA Stock Chart & Stats
kr10.72
-kr0.18(-1.05%)
At close: 4:00 PM EST
kr10.72
-kr0.18(-1.05%)
Day’s Range― - ―
52-Week Rangekr8.20 - kr18.32
Previous CloseN/A
Volume45.94K
Average Volume (3M)247.68K
Market Cap
kr895.03M
Enterprise Valuekr861.64M
Total Cash (Recent Filing)kr80.68M
Total Debt (Recent Filing)kr7.56M
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Jul 17, 2026EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding99,336,960
10 Day Avg. Volume186,290
30 Day Avg. Volume247,675
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)1.13
Price to Sales (P/S)5.10
P/FCF Ratio-13.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.26
Revenue Forecast (FY)kr213.23M
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetExtremely low debt provides durable financial flexibility: it reduces refinancing risk and preserves capacity to fund commercialization, R&D, or cushion cash burn. This conservatism supports multi-quarter survival and strategic optionality while the business seeks operating inflection.
High Gross MarginsSustained ~71% gross margin indicates strong unit economics from proprietary pharmaceutical and device mix. If adoption grows, these margins can convert incremental revenue into operating leverage faster than low-margin peers, aiding durable path to profitability.
Recurring Consumables And Niche Product FocusA focused inhaled-sedation franchise with consumable components creates recurring, per-patient revenue and a specialized market niche. This structural revenue model supports predictable refill streams and customer stickiness as hospital protocols and device deployments scale over months.
Bears Say
Structurally Loss-makingPersistent negative operating and net margins show the business still consumes earnings at scale. Ongoing losses erode equity, limit reinvestment capacity, and mean profitability depends on meaningful revenue growth or material cost restructuring to generate sustainable returns.
Negative Operating And Free Cash FlowSustained negative OCF and large negative FCF increase reliance on existing liquidity or new financing. This cash burn constrains long-term commercialization investments and elevates execution risk if capital markets access tightens or fundraising dilutes shareholders.
Weak Top-line MomentumFlat-to-declining revenue prevents operating leverage and delays break-even. Weak top-line traction implies adoption of inhaled sedation isn't accelerating; without clear, sustained revenue growth, margin improvement and self-funded expansion remain uncertain.
Sedana Medical AB News
SEDANA FAQ
What was Sedana Medical AB’s price range in the past 12 months?
Sedana Medical AB lowest stock price was kr8.20 and its highest was kr18.32 in the past 12 months.
What is Sedana Medical AB’s market cap?
Sedana Medical AB’s market cap is kr895.03M.
When is Sedana Medical AB’s upcoming earnings report date?
Sedana Medical AB’s upcoming earnings report date is Jul 17, 2026 which is in 35 days.
How were Sedana Medical AB’s earnings last quarter?
Sedana Medical AB released its earnings results on Apr 23, 2026. The company reported -kr0.04 earnings per share for the quarter, beating the consensus estimate of -kr0.044 by kr0.004.
Is Sedana Medical AB overvalued?
According to Wall Street analysts Sedana Medical AB’s price is currently Overvalued.
Does Sedana Medical AB pay dividends?
Sedana Medical AB does not currently pay dividends.
What is Sedana Medical AB’s EPS estimate?
Sedana Medical AB’s EPS estimate is -0.08.
How many shares outstanding does Sedana Medical AB have?
Sedana Medical AB has 99,336,960 shares outstanding.
What happened to Sedana Medical AB’s price movement after its last earnings report?
Sedana Medical AB reported an EPS of -kr0.04 in its last earnings report, beating expectations of -kr0.044. Following the earnings report the stock price went down -2.302%.
Which hedge fund is a major shareholder of Sedana Medical AB?
Currently, no hedge funds are holding shares in SE:SEDANA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sedana Medical AB
Sedana Medical AB (publ) is a medical technology firm that engineers, promotes, and distributes healthcare devices both within Sweden and across global markets. Its product portfolio includes the Sedaconda ACD-L and Sedaconda ACD, single-use medical tools designed for delivering volatile anesthetics, alongside the Sedaconda Syringe (a 50/60ml syringe) and a Sedaconda ACD starter kit. The company also provides FlurAbsorb and FlurAbsorb-S, active carbon filtration systems engineered to collect residual anesthetic gases discharged by ventilators. Complementing these are the FlurAbsorb accessory kit, which facilitates connecting ventilator exhausts and gas monitors to the filters, and the FlurAbsorb mount, used to secure the filter during anesthetic gas removal. Further offerings encompass the AMG-06 Gas Monitor, which enables ongoing, non-invasive sidestream measurement of carbon dioxide and anesthetic levels in inhaled and exhaled breaths. Additionally, they supply the Sedaconda Filling Adapter, a disposable tool for securely and simply transferring isoflurane from its container to a Sedaconda Syringe, as well as an array of supplemental items like DRYLINE II Water Traps, the WaterLock 2 water trap, Nafion Dryer Tubing, and Respiratory Gas Monitoring Lines. Established in 1999, Sedana Medical AB (publ) maintains its corporate headquarters in Danderyd, Sweden.
Technical Analysis
Options Prices
Currently, No data available
---